SMARCA4 and neoplasm: Mutations in the SMARCA4 gene are recurrent and typical of SCCOHT as they have been identified in 85–100% of SCCOHT tumours.7–10 Molecular screening for SMARCA4 mutations could provide a useful tool to diagnose SCCOHT.